Protein and gene expression of estrogen receptor alpha and nuclear morphology of two breast cancer cell lines after different fixation methods

Experimental and Molecular Pathology

Volumn 88, Issue 2, 2010, Pages 265-271

  Nykänen, Marjukka ^a   Kuopio, Teijo ^a  

^a CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

Author keywords

Breast cancer; Estrogen receptor; Fixation; Immunohistochemistry; Q PCR

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL STRUCTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL NUCLEUS; ESTROGEN RECEPTOR ALPHA; FEMALE; FORMALDEHYDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA, NEOPLASM; STAINING AND LABELING; TISSUE FIXATION;

EID: 77950627061     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.12.003     Document Type: Article

References (26)

1. Abba M.C., Hu Y., Sun H., Drake J.A., Gaddis S., Baggerly K., Sahin A., Aldaz C.M. Gene expression signature of estrogen receptor α status in breast cancer. BMC Genomics 2005, 6:37.
2. Andersson A-N., Strömberg S., Bäckvall H., Kamp C., Uhlen M., Wester K., Pontén F. Analysis of protein expression in cell microarrays; a tool for antibody proteomics. J. Histochem. Cytochem. 2006, 54:1413-1423.
3. Bussolati G., Leonardo E. Technical pitfalls potentially affecting diagnoses in immunohistochemistry. J. Clin. Pathol. 2008, 61:1184-1192.
4. Cano G., Milanezi F., Leitão D., Ricardo S., Brito M.J., Schmitt F.C. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn. Cytopathol. 2003, 29:207-211.
5. Cox L.M., Schray C.L., Luster C.N., Stewart Z.S., Korytko P.J., Khan K.N.M., Paulauskis J.D., Dunstan R.W. Assessment of fixatives, fixation, and tissue processing on morphology and RNA integrity. Exp. Mol. Pathol. 2006, 80:183-191.
6. Cronin M., Pho M., Dutta D., Stephans J.C., Shak S., Kiefer M.C., Esteban J.M., Baker J.B. Measurement of gene expression in archival paraffin-embedded tissue. Am. J. Pathol. 2004, 164:35-42.
7. Diaz L.K., Sneige N. Estrogen receptor analysis for breast cancer. Adv. Anat. Pathol. 2005, 12:10-19.
8. Espinosa E., Vara J.A.F., Redondo A., Sánchez J.J., Hardisson D., Zamora P., Pastrana F.G., Cejas P., Martínez B., Su'arez A., Calero F., Barón G. Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study. J. Clin. Oncol. 2005, 23:7278-7285.
9. Fabbro D., Küng W., Roos W., Regazzi R., Eppenberger U. Epidermal growth factor binding and protein kinase c activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res. 1986, 46:2720-2725.
10. Gillespie J.W., Best C.J.M., Bichsel V.E., Cole K.A., Greenhut S.F., Hewitt S.M., Ahram M., Gathright Y.B., Merino M.J., Strausberg R.L., Epstein J.I., Hamilton S.R., Gannot G., Baibakova G.V., Calvert V.S., Flaig M.J., Chuaqui R.F., Herring J.C., Pfeifer J., Petricoin E.F., Linehan W.M., Duray P.H., Bova G.S., Emmert-Buck M.R. Evaluation of non-formalin tissue fixation for molecular profiling studies. Am. J. Pathol. 2002, 160:449-457.
11. Godfrey T.E., Kim S-H., Chavira M., Ruff D.W., Warren R.S., Gray J.W., Jensen R.H. Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction. J. Mol. Diagn. 2000, 2:84-91.
12. Goldstein N.S., Ferkowicz M., Odish E., Mani A., Hastah F. Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma. Am. J. Clin. Pathol. 2003, 120:86-92.
13. Kerstens H.M.J., Robbes J.C.M., Poddighe P.J., Melchers W.J.G., Boonstra H., de Wilde P.C.M., Macville M.V.E., Hanselaar A.G.J.M. AgarCyto: a novel cell-processing method for multiple molecular diagnostic analyses of the uterine cervix. J. Histochem. Cytochem. 2000, 48:709-718.
14. Nadji M., Gomez-Fernandez C., Ganjei-Azar P., Morales A.R. Immunohistochemistry of estrogen and progesterone receptors reconsidered. Am. J. Clin. Pathol. 2005, 123:21-27.
15. Perread L., Fan C., Quackenbush J.F., Mullins M., Gauthier N.P., Nelson E., Mone M., Hansen H., Buys S., Rasmussen K., Orrico A.R., Dreher D., Wslters R., Parker J., Hu Z., He X., Palazzo J.P., Olopade O.I., Szabo A., Perou C.M., Bernard P.S. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res. 2006, 8:R23.
16. Poola I., Yue Q. Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive, and negative breast cancer tissues. BMC Cancer 2007, 7:56.
17. Potemski P., Pluciennik E., Bednarek A.K., Kusinska R., Kubial R., Kordek R. Evaluation of estrogen receptor expression in breast cancer by quantification of mRNA. Histopathology 2007, 51:827-836.
18. Schnitt S.J. Estrogen receptor testing of breast cancer in current clinical practice: what's the question. J. Clin. Oncol. 2006, 24:1797-1799.
19. Specht K., Richter T., Müller U., Walch A., Werner M., Höfler H. Quantitative Gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am. J. Pathol. 2001, 158:419-429.
20. Srinivasan M., Sedmak D., Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am. J. Pathol. 2002, 161:1961-1971.
21. Titford M.E., Horenstein M.G. Histomorphologic assessment of formalin substitute fixatives for diagnostic surgical pathology. Arch. Pathol. Lab. Med. 2005, 129:502-506.
22. Walker R.A. Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology 2006, 49:406-410.
23. Walker R.A. Immunohistochemical markers as predictive tools for breast cancer. J. Clin. Pathol. 2008, 61:689-696.
24. Wolff A.C., Hammond M.E.H., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., Dowsett M., Fitzgibbons P.L., Hanna W.M., Langer A., McShane L.M., Paik S., Pegram M.D., Perez E.A., Press M.F., Rhodes A., Sturgeon C., Taube S.E., Vance G.H., van de Vijver M., Wheeler T.M., Hayes D.F. American society of clinical oncology/college of American pathologist guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch. Pathol. Lab. Med. 2007, 131:18-43.
25. Yaziji H., Barry T. Diagnostic immunohistochemistry: what can go wrong. Adv. Anat. Pathol. 2006, 13:238-246.
26. Yeap B.H., Muniandy S., Lee S-K., Sabaratnam S., Singh M. Specimen shrinkage and its influence on margin assessment in breast cancer. Asian J. Surg. 2007, 30:183-187.